For people with T2D, a phase 2 trial showed that 12 weeks of efinopegdutide achieve up to 7.9% WL (compared to 0.7% WL with placebo) without actual improvement in HbA1c [78]
The study reveals that the SLC25A39 transporter, which imports glutathione into mitochondria, is essential for cancer spread, and elevated SLC25A39 expression correlates with poorer survival outcomes in breast cancer patients, suggesting potential therapeutic targeting opportunities
Table of Contents What are hexarelin and ipamorelin pharmacologically
For a long time, this medication was the only drug of its type, but in recent years, other GLP-1 agonists have been approved for both the treatment of diabetes and the treatment of obesity
We wondered how these drugs may play a role in treatment patterns, particularly in populations with overweight or obesity